Publications by the researcher in collaboration with Gregory Y.H. Lip (217)

2025

  1. Optimal Medical Therapy for Heart Failure and Integrated Care in Patients With Atrial Fibrillation: A Report From the ESC-EHRA EORP Atrial Fibrillation Long-Term General Registry

    Journal of the American Heart Association, Vol. 14, Núm. 1, pp. e030499

  2. Poor clinical outcomes associated to multimorbidity, frailty and malnutrition in patients with atrial fibrillation

    Journal of Nutrition, Health and Aging, Vol. 29, Núm. 1

  3. The Neutrophil-to-Lymphocyte Ratio Is an Independent Inflammatory Biomarker for Adverse Events in Patients With Atrial Fibrillation: Insights From the Murcia AF Project II (MAFP-II) Cohort Study

    Clinical cardiology, Vol. 48, Núm. 2, pp. e70102

2024

  1. Dynamic assessment of CHA2DS2-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients

    Revista Espanola de Cardiologia, Vol. 77, Núm. 10, pp. 835-842

  2. Endothelial activation, Cell-Cell Interactions, and Inflammatory Pathways in Postoperative Atrial Fibrillation Following Cardiac Surgery.

    Biomedical Journal, pp. 100821

  3. Practical approach for atrial cardiomyopathy characterization in patients with atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 77, Núm. 8, pp. 656-666

2023

  1. Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis

    Journal of Clinical Medicine, Vol. 12, Núm. 8

  2. Clinical implications of different types of dementia in patients with atrial fibrillation: Insights from a global federated health network analysis

    Clinical Cardiology, Vol. 46, Núm. 6, pp. 656-662

  3. Contemporary management of atrial fibrillation and the predicted vs. absolute risk of ischaemic stroke despite treatment: a report from ESC-EHRA EORP-AF Long-Term General Registry

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 25, Núm. 2, pp. 277-282

  4. Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients

    Journal of Clinical Medicine, Vol. 12, Núm. 3

  5. Ibrutinib use and adverse cardiovascular outcomes: A United States federated electronic medical records analysis

    European Journal of Internal Medicine

  6. Imaging in atrial fibrillation: A way to assess atrial fibrosis and remodeling to assist decision-making

    American Heart Journal, Vol. 258, pp. 1-16

  7. Impact of particulate matter on the incidence of atrial fibrillation and the risk of adverse clinical outcomes: A review

    Science of the Total Environment, Vol. 880

  8. Molecular mechanisms of postoperative atrial fibrillation in patients with obstructive sleep apnea

    FASEB Journal, Vol. 37, Núm. 6

  9. Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?

    Biomedicine and Pharmacotherapy, Vol. 158

  10. Simplified Geleijnse score for identifying chest pain features associated with coronary ischemia

    Heart and Lung, Vol. 59, pp. 61-66

  11. The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort

    Journal of General Internal Medicine, Vol. 38, Núm. 2, pp. 315-323

  12. Thoracic aortic aneurysm and atrial fibrillation: clinical associations with the risk of stroke from a global federated health network analysis

    Internal and Emergency Medicine, Vol. 18, Núm. 2, pp. 423-428

2022

  1. A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry

    Expert Opinion on Pharmacotherapy, Vol. 23, Núm. 12, pp. 1457-1465

  2. Anthropometric Measures and Risk of Cardiovascular Disease: Is there an Opportunity for Non-Traditional Anthropometric Assessment? A Review

    Reviews in Cardiovascular Medicine, Vol. 23, Núm. 12